Clinical Trials to Validate AI-Driven Drug Repurposing
Convoca: Cures Within Reach’s (CWR)
Termini: 26/06/2026

• CWR is interested in approved drugs, biologics, eligible cellular/gene therapies or combination therapies that could be repurposed to create “new” treatments for any unsolved disease. While CWR is accepting submissions in any disease area, CWR has a preference for clinical trials addressing rare diseases.